Author's posts
TRICARE For All: Wrong For Iowa And America
Doctors can accept TRICARE’s lower rates because their practices also receive payments from private payers that fill the gap and keep their practices afloat.
New Administration Action Could Give 11 Million Workers More Health Insurance Options
The Trump administration’s new HRA rule could transform the employer-based health insurance market in much the same way that 401(k) changed the retiree benefit world. It will lead to more choices of more affordable health coverage for employees.
A Closer Look At The Drug Rebate Proposal
The administration’s proposal to reform rebates is promising and deserves a close look; More immediate actions can drive savings for seniors in the short term
Rebates And Drug Costs: What The New Proposal Would Mean
Pulling back the curtain on the hidden deals that drive up prices for consumers at the pharmacy counter.
Don’t Panic: There’s Time To Get ObamaCare Replacement Right
States have immediate options to help their health insurance markets begin to heal from the damage the health overhaul law has done.
A Nudge Toward Formulary Changes
Health plans need to step up and quickly make the lower-price version of Repatha available to patients.
Amgen Announces Major Price Cut For Its Breakthrough Cholesterol Drug
The price cut is a market-based approach that is much more likely to succeed in lowering drug prices while allowing investments in research for new innovative therapies to continue.
Real Solutions, Not Empty Promises
We believe there are better ways to help people with pre-existing condition than the failed and flawed health overhaul law.
